Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aegerion Pharmaceuticals Inc

+ Add to Watchlist


19.6800 USD 0.1400 0.71%

As of 20:10:00 ET on 05/28/2015.

Company Profile for Aegerion Pharmaceuticals Inc (AEGR)

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.

Contact Information

Aegerion Pharmaceuticals Inc

101 Main Street
Suite 1850
Cambridge, MA 02142
United States
Phone: 1-617-500-7867
Fax: 1-617-945-7968

Key Executives for Aegerion Pharmaceuticals Inc (AEGR)

Marc D BeerChief Executive OfficerDavid AubuchonActing CFO/Chief Accounting Ofcr
Craig FraserChief Operating OfficerMark SumerayChief Medical Officer
Carolina AlarcoPresident:InternationalMartha J CarterSenior VP/Chief Regulatory
Anne Marie CookSenior VP/Secretary/Gen CnslAmanda MurphyAssoc Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil